Mohamed Kabbout

531 total citations
11 papers, 353 citations indexed

About

Mohamed Kabbout is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Mohamed Kabbout has authored 11 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Mohamed Kabbout's work include Lung Cancer Treatments and Mutations (5 papers), RNA modifications and cancer (3 papers) and Lung Cancer Diagnosis and Treatment (2 papers). Mohamed Kabbout is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), RNA modifications and cancer (3 papers) and Lung Cancer Diagnosis and Treatment (2 papers). Mohamed Kabbout collaborates with scholars based in United States, India and Lebanon. Mohamed Kabbout's co-authors include Ignacio I. Wistuba, Humam Kadara, Junya Fujimoto, Melinda Garcia, Chi‐Wan Chow, J. Jack Lee, Carmen Behrens, Luisa M. Solis, Diane D. Liu and Denise M. Woods and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Mohamed Kabbout

11 papers receiving 347 citations

Peers

Mohamed Kabbout
Comparison fields: 5 of 55
  • Molecular Biology 242
  • Pulmonary and Respiratory Medicine 128
  • Cancer Research 126
  • Oncology 82
  • Immunology 38
Huangyang Meng China
Gaofeng Li China
Xiao Dong China
Biao He United States
Yuichi Ishikawa Japan
Maryann Mikhail United States
Eric J. Whitman United States
Gillian A. Horne United Kingdom
Marcin Nicoś Poland
Daisaku Ashikari Japan
Huangyang Meng China View profile →
Citations per field, relative to Mohamed Kabbout
Mohamed Kabbout · 1×
Citations per year, relative to Mohamed Kabbout
Mohamed Kabbout · 1×

Countries citing papers authored by Mohamed Kabbout

Since Specialization
Citations

This map shows the geographic impact of Mohamed Kabbout's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohamed Kabbout with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohamed Kabbout more than expected).

Fields of papers citing papers by Mohamed Kabbout

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohamed Kabbout. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohamed Kabbout. The network helps show where Mohamed Kabbout may publish in the future.

Co-authorship network of co-authors of Mohamed Kabbout

This figure shows the co-authorship network connecting the top 25 collaborators of Mohamed Kabbout. A scholar is included among the top collaborators of Mohamed Kabbout based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohamed Kabbout. Mohamed Kabbout is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
# Title Journal Authors Indexed citations
1 Adenovirus and Oxaliplatin cooperate as agnostic sensitizers for immunogenic cell death in colorectal carcinoma Human Vaccines & Immunotherapeutics J. Milburn Jessup, Mohamed Kabbout et al. 9
2 Two ICD Inducers are better than one for induction of anti-tumor immunity in cold carcinomas The Journal of Immunology J. Milburn Jessup, Mohamed Kabbout et al. 1
3 MicroRNA 17-92 Cluster Mediates ETS1 and ETS2-Dependent RAS-Oncogenic Transformation PLoS ONE Mohamed Kabbout, Duaa Dakhlallah et al. 20
4 Transcriptomic Architecture of the Adjacent Airway Field Cancerization in Non–Small Cell Lung Cancer JNCI Journal of the National Cancer Institute Humam Kadara, Junya Fujimoto et al. 59
5 ETS2 Mediated Tumor Suppressive Function and MET Oncogene Inhibition in Human Non–Small Cell Lung Cancer Clinical Cancer Research Mohamed Kabbout, Melinda Garcia et al. 116
6 Characterizing the Molecular Spatial and Temporal Field of Injury in Early-Stage Smoker Non–Small Cell Lung Cancer Patients after Definitive Surgery by Expression Profiling Cancer Prevention Research Humam Kadara, Li Shen et al. 26
7 g-Protein Coupled Receptor Family C, Group 5, Member A ( gprc5a ) Expression Is Decreased in the Adjacent Field and Normal Bronchial Epithelia of Patients with Chronic Obstructive Pulmonary Disease and Non–Small-Cell Lung Cancer Journal of Thoracic Oncology Junya Fujimoto, Humam Kadara et al. 37
8 Abstract 1721: Gene expression profiling of lung tumors and matched normal airways reveals common and disparate aberrant pathways in squamous cell carcinoma and adenocarcinoma development and potential markers for detection and targets for chemoprevention in early stage lung cancer Cancer Research Humam Kadara, Junya Fujimoto et al. 1
9 Transcription Factor ets-2 Plays an Important Role in the Pathogenesis of Pulmonary Fibrosis American Journal of Respiratory Cell and Molecular Biology Christopher P. Baran, Gerard J. Nuovo et al. 13
10 Pulmonary adenocarcinoma: A renewed entity in 2011 Respirology Humam Kadara, Mohamed Kabbout et al. 63
11 Stage‐specific effect of N‐(4‐hydroxyphenyl)retinamide on cell growth in squamous cell carcinogenesis Molecular Carcinogenesis Mohamed Kabbout, Fadia R. Homaidan et al. 8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026